Optomed Oyj

Symbol: OPTOMED.HE

HEL

5.36

EUR

Market price today

  • -20.1682

    P/E Ratio

  • 4.2353

    PEG Ratio

  • 95.28M

    MRK Cap

  • 0.00%

    DIV Yield

Optomed Oyj (OPTOMED-HE) Financial Statements

On the chart you can see the default numbers in dynamics for Optomed Oyj (OPTOMED.HE). Companys revenue shows the average of NaN M which is NaN % gowth. The average gross profit for the whole period is NaN M which is NaN %. The average gross profit ratio is NaN %. The net income growth for the company last year performance is NaN % which equals NaN % % on average for the whole company history.,

Balance Sheet

Diving into the fiscal trajectory of Optomed Oyj, we observe an average asset growth. This rate, interestingly, stands at , reflecting both the company's highs and lows. When compared quarter-over-quarter, this figure adjusts to . A look back at the past year reveals a total asset change of NaN. Shareholder value, as depicted by the total shareholder equity, is valued at NaN in the reporting currency. The year over year change in this aspect is NaN%.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015

balance-sheet.row.cash-and-short-term-investments

07.18.56.8
10.6
18.9
2
1
1.6
2.8

balance-sheet.row.short-term-investments

0000
0
0
0
0
0
0

balance-sheet.row.net-receivables

03.24.64.6
3.6
5.1
2.9
0
1.7
2.3

balance-sheet.row.inventory

02.832.9
2.5
2.5
1.1
1.1
1.6
1.1

balance-sheet.row.other-current-assets

00.64.60
1
-1
0.5
1.6
0
0

balance-sheet.row.total-current-assets

013.116.114.4
16.8
25.5
6.5
3.7
4.9
6.2

balance-sheet.row.property-plant-equipment-net

02.22.31.6
1.5
1.5
1.8
1.2
1
0.3

balance-sheet.row.goodwill

04.34.34.3
4.3
4.3
4.3
0
0
0

balance-sheet.row.intangible-assets

09.58.68.7
8.5
8.4
8.5
5
4.1
0

balance-sheet.row.goodwill-and-intangible-assets

013.712.913
12.8
12.7
12.8
5
4.1
3.1

balance-sheet.row.long-term-investments

008.68.3
0
0
0
0
0
0

balance-sheet.row.tax-assets

0000
0
0
0
0
0
0

balance-sheet.row.other-non-current-assets

00-8.6-8.3
0
0
0
0
0
0

balance-sheet.row.total-non-current-assets

01615.214.6
14.3
14.2
14.6
6.2
5.1
3.4

balance-sheet.row.other-assets

0000
0
0
0
0
0
0

balance-sheet.row.total-assets

029.131.329
31.1
39.6
21.1
9.9
10
9.5

balance-sheet.row.account-payables

03.50.90.9
0.6
1.7
0.7
0.5
0.7
0.7

balance-sheet.row.short-term-debt

01.51.41.7
0.8
2.2
7.6
0.8
0.8
0.8

balance-sheet.row.tax-payables

0000
0
0
0
0
0
0

balance-sheet.row.long-term-debt-total

03.45.36.6
7
8.8
3.7
5.4
3
2.9

Deferred Revenue Non Current

004.35.8
0
0
3.9
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-

balance-sheet.row.other-current-liab

0030
0
3.6
0
0
0
0

balance-sheet.row.total-non-current-liabilities

03.75.77
7.5
9.4
5.1
6.1
3.6
3.5

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

01.51.51.2
1.2
1.1
1.1
0.6
0.5
0

balance-sheet.row.total-liab

08.71111.9
11
17
15.6
8.8
6.5
5.8

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0

balance-sheet.row.common-stock

00.10.10.1
0.1
0.1
0
0
0
0

balance-sheet.row.retained-earnings

0-31.5-27.2-22
-18.1
-15.4
-13.7
-12.5
-10.3
-7.9

balance-sheet.row.accumulated-other-comprehensive-income-loss

00.346.938.4
0.2
37.4
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

051.40.50.5
38
0.5
19.2
13.7
13.8
11.6

balance-sheet.row.total-stockholders-equity

020.420.317.1
20.1
22.6
5.6
1.2
3.5
3.7

balance-sheet.row.total-liabilities-and-stockholders-equity

029.131.329
31.1
39.6
21.1
9.9
10
9.5

balance-sheet.row.minority-interest

0000
0
0
0
0
0
0

balance-sheet.row.total-equity

020.420.317.1
20.1
22.6
5.6
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-

Total Investments

008.68.3
0
0
0
0
0
0

balance-sheet.row.total-debt

04.96.78.2
7.7
11
11.3
6.2
3.8
3.7

balance-sheet.row.net-debt

0-2.3-1.81.4
-2.9
-7.8
9.3
5.1
2.2
0.9

Cash Flow Statement

The financial landscape of Optomed Oyj has seen a noteworthy change in free cash flow over the last period, exhibiting a shift of NaN. The company recently extended its share capital by issuing NaN, marking a difference of NaN compared to the previous year. The company's investing activities resulted in net cash usage, amounting to NaN in the reporting currency. This is a shift of NaN from the previous year. In the same period, the company recorded NaN, NaN, and NaN, which are significant to understanding the company's investment and repayment strategies. The company's financing activities led to a net cash usage of NaN, with a year over year difference of NaN. Furthermore, the company allocated NaN for dividend payouts to its shareholders. At the same time, it engaged in other financial maneuvers, referred to as NaN, which also significantly impacted its cash flow during this period. These components, taken together, paint a comprehensive picture of the company's financial status and strategic approach towards cash flow management.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016

cash-flows.row.net-income

0-4.4-5.5-4.2
-3.2
-2.9
-1.3
-2.9
-2.8

cash-flows.row.depreciation-and-amortization

02.23.12.7
2.2
2.3
1.8
1
0.7

cash-flows.row.deferred-income-tax

0-0.1-0.3-0.3
-0.4
-0.5
0
0
0

cash-flows.row.stock-based-compensation

00.10.30.3
0.4
0.5
0
0
0

cash-flows.row.change-in-working-capital

01.10.3-1.8
-2
0.3
-1.1
0.5
0.9

cash-flows.row.account-receivables

01.10.2-1.4
0.5
-0.8
0
0
0

cash-flows.row.inventory

00.1-0.1-0.3
-0.1
-1.3
-0.1
0.6
-0.3

cash-flows.row.account-payables

0-0.10.20
-2.5
2.4
0
0
0

cash-flows.row.other-working-capital

0000
0.1
0
-1.1
0
1.1

cash-flows.row.other-non-cash-items

00.5-0.40.4
0.2
0.5
0.6
0.6
0.4

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-2.4-3-2.6
-1.8
-1.4
-1.7
-1.9
-1.9

cash-flows.row.acquisitions-net

0000
0
0
-7.6
0
0

cash-flows.row.purchases-of-investments

0000
0
0
0
0
0

cash-flows.row.sales-maturities-of-investments

0000
0
0
0
0
0

cash-flows.row.other-investing-activites

0000
0
0
0.5
0
0

cash-flows.row.net-cash-used-for-investing-activites

0-2.4-3-2.6
-1.8
-1.4
-8.8
-1.9
-1.9

cash-flows.row.debt-repayment

0-1.9-0.9-0.3
-3.4
-0.5
-0.5
-0.4
-0.8

cash-flows.row.common-stock-issued

0491
0.1
23
5.5
0
2

cash-flows.row.common-stock-repurchased

0000
0
0
0
0
0

cash-flows.row.dividends-paid

0000
0
0
0
0
0

cash-flows.row.other-financing-activites

0-0.5-1.11
-0.4
-4.4
4.9
2.5
0.4

cash-flows.row.net-cash-used-provided-by-financing-activities

01.671.6
-3.7
18.1
9.8
2.1
1.5

cash-flows.row.effect-of-forex-changes-on-cash

000.10.1
0.1
0
0
-0.1
0

cash-flows.row.net-change-in-cash

0-1.41.7-3.8
-8.3
16.9
1
-0.6
-1.2

cash-flows.row.cash-at-end-of-period

07.18.56.8
10.6
18.9
2
1
1.6

cash-flows.row.cash-at-beginning-of-period

08.56.810.6
18.9
2
1
1.6
2.8

cash-flows.row.operating-cash-flow

0-0.6-2.4-2.9
-2.8
0.2
-0.1
-0.8
-0.8

cash-flows.row.capital-expenditure

0-2.4-3-2.6
-1.8
-1.4
-1.7
-1.9
-1.9

cash-flows.row.free-cash-flow

0-3-5.4-5.5
-4.6
-1.3
-1.8
-2.7
-2.7

Income Statement Row

Optomed Oyj's revenue saw a change of NaN% compared with the previous period. The gross profit of OPTOMED.HE is reported to be NaN. The company's operating expenses are NaN, showing a change of NaN% from the last year. The expenses for depreciation and amortization are NaN, which is a NaN% change from the last accounting period. Operating expenses are reported to be NaN, which shows a NaN% year-over-year change. Selling and marketing expenses are NaN, which is a NaN% change compared to the previous year. The EBITDA based on the recent numbers is NaN, representing a NaN% year-over-year growth. The operating income is NaN, which shows a NaN% change when compared to the previous year. The change in the net income is NaN%. The net income for the last year was NaN.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016

income-statement-row.row.total-revenue

015.114.714.8
13
15
14.5
6.9
6.6

income-statement-row.row.cost-of-revenue

04.95.45.1
4.2
5.3
5
3.1
3

income-statement-row.row.gross-profit

010.29.29.7
8.8
9.7
9.5
3.8
3.6

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-

income-statement-row.row.other-expenses

001212.2
10.1
10.6
10.2
5.5
4.8

income-statement-row.row.operating-expenses

014.213.914.1
11.5
11.9
10.2
6.6
6.3

income-statement-row.row.cost-and-expenses

019.119.319.2
15.8
17.2
15.1
9.7
9.2

income-statement-row.row.interest-income

00.500
0
0
0
0
0

income-statement-row.row.interest-expense

010.10.1
0.2
0.4
0.6
0.2
0.1

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

0-0.5-0.90
-0.5
-0.7
-0.8
-0.1
-0.1

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-

income-statement-row.row.other-operating-expenses

001212.2
10.1
10.6
10.2
5.5
4.8

income-statement-row.row.total-operating-expenses

0-0.5-0.90
-0.5
-0.7
-0.8
-0.1
-0.1

income-statement-row.row.interest-expense

010.10.1
0.2
0.4
0.6
0.2
0.1

income-statement-row.row.depreciation-and-amortization

02.23.43.4
2
1.9
1.8
1
0.7

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-

income-statement-row.row.operating-income

0-4-4.7-4.4
-2.7
-2.2
-0.7
-2.8
-2.6

income-statement-row.row.income-before-tax

0-4.5-5.6-4.3
-3.2
-3
-1.2
-2.9
-2.8

income-statement-row.row.income-tax-expense

0-0.1-0.1-0.1
-0.1
-0.1
0
0
0

income-statement-row.row.net-income

0-4.4-5.5-4.2
-3.2
-2.9
-1.3
-2.9
-2.8

Frequently Asked Question

What is Optomed Oyj (OPTOMED.HE) total assets?

Optomed Oyj (OPTOMED.HE) total assets is 29079000.000.

What is enterprise annual revenue?

The annual revenue is N/A.

What is firm profit margin?

Firm profit margin is 0.678.

What is company free cash flow?

The free cash flow is -0.180.

What is enterprise net profit margin?

The net profit margin is -0.294.

What is firm total revenue?

The total revenue is -0.263.

What is Optomed Oyj (OPTOMED.HE) net profit (net income)?

The net profit (net income) is -4441000.000.

What is firm total debt?

The total debt is 4858000.000.

What is operating expences number?

The operating expences are 14217000.000.

What is company cash figure?

Enretprise cash is 0.000.